ibrutinib
janssen,Abbvie
['lymsm', 'improve', 'lymphoma', 'mantle,(-dismantle)']
 new #cancerresearch from shows adding ibrutinib to standard of care for mantle cell #lymphoma improves progression-free survival by 50% #asco22 #lymsm
Timely, trusted, compassionate doctor-approved info from @ASCO
https://t.co/K04SLVsoar

We cannot answer individual medical questions.

Retweet ?Endorsement